CRISPR‐driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges
Clinical and Translational Medicine · 2025-10 · 15 (10)
DOI: 10.1002/ctm2.70482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 26.09.2025. Verfasst von Zilong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Basic Research Project of the Key Research Program of Colleges and Universities in Henan Province, China Postdoctoral Science Foundation, Joint Funds of Science and Technology Research and Development Plan of Henan Province.
Abstract (Originalsprache)
Background
In the realm of public health, among the primary perils menacing human well‐being, the issue of pathogen infection persists as a significant concern. Precise and timely diagnosis of diseases constitutes the bedrock for effective therapeutic interventions and epidemiological monitoring. Hence, it is crucial to develop quick, sensitive, and highly effective methods for identifying pathogen and their variants. Material and methods This article reviews the recent research progress in the CRISPR/Cas system for detecting nucleic acids, with an emphasis on CRISPR/Cas9, CRISPR/Cas12, and CRISPR/Cas13. Initially, we provided a concise overview of the nucleic acid detection mechanism utilizing the CRISPR/Cas system. Subsequently, we dissect the molecular mechanisms of CRISPR tools, compare their clinical efficacy against traditional methods, and explore frontier innovations such as amplification‐free detection and AI integration.
Conclusion
Ultimately, we argue that CRISPR diagnostics must evolve beyond technical optimization to embrace ecological adaptability, ensuring that precision medicine serves as a bridge‐rather than a barrier‐to global health equity. Key points Core Mechanism : Explains the molecular basis of CRISPR‐Cas (Cas9, Cas12, Cas13) for nucleic acid detection, leveraging crRNA‐guided targeting and trans‐cleavage activity for ultra‐sensitive (aM level) and specific pathogen identification. Superior Performance : Outperforms traditional methods in speed, sensitivity, and cost, making it ideal for point‐of‐care use in resource‐limited settings. Cutting‐Edge Innovations : Covers key advances like amplification‐free detection, portable device integration, and multiplex platforms. Translation Challenges : Discusses hurdles in clinical adoption, including inhibitor interference in complex samples, scalability limitations, the need for multi‐center clinical data, and varying regional regulations. Future Outlook : Highlights emerging directions such as integrated “sample‐to‐result” systems and AI integration, while also addressing associated biosafety and ethical concerns, calling for robust regulatory frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical College, Henan University of Chinese Medicine, Zhengzhou, China.
- Henan Engineering Research Center for Chinese Medicine Foods for Special Medical Purpose, Zhengzhou, China.
ORCID-Profile: Zilong Wang
Förderung
- the Basic Research Project of the Key Research Program of Colleges and Universities in Henan Province
- China Postdoctoral Science Foundation
- Joint Funds of Science and Technology Research and Development Plan of Henan Province
- Natural Science Foundation of Henan Province
- Basic Research Project of the Key Research Program of Colleges and Universities in Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, Z., Wang, Q., Zhang, J., Li, B., Li, Y., Chen, Z., Guo, D., & Feng, S. (2025). CRISPR‐driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges. Clinical and Translational Medicine, 15(10). https://doi.org/10.1002/ctm2.70482
Vancouver
Wang Z, Wang Q, Zhang J, Li B, Li Y, Chen Z, et al. CRISPR‐driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges. Clinical and Translational Medicine. 2025;15(10). doi:10.1002/ctm2.70482
BibTeX
@article{Wang2025,
author = {Wang, Zilong and Wang, Qianqian and Zhang, Jiaming and Li, Bingyu and Li, Yuke and Chen, Zhengbo and Guo, Dandan and Feng, Shuying},
title = {CRISPR‐driven diagnostics: Molecular mechanisms, clinical efficacy and translational challenges},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {10},
doi = {10.1002/ctm2.70482}
}
EUVIMED